Literature DB >> 14404640

Modification of erythrocyte receptors by a factor in adenovirus suspensions.

J A KASEL, W P ROWE, J L NEMES.   

Abstract

Keywords:  ADENOVIRUS; HEMAGGLUTINATION

Mesh:

Substances:

Year:  1960        PMID: 14404640     DOI: 10.1016/0042-6822(60)90035-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  10 in total

1.  [PROPERTIES OF ADENOVIRUS HEMAGGLUTININS].

Authors:  H BAUER; R WIGAND
Journal:  Z Hyg Infektionskr       Date:  1963-04-22

2.  Heterogeneity of adenovirus hemagglutinins. (Brief report).

Authors:  H BAUER; R WIGAND
Journal:  Arch Gesamte Virusforsch       Date:  1962

3.  Thin-layer chromatography of lipids in adenovirus-treated human erythrocytes.

Authors:  A Lengyel; M Klembala; I Nász
Journal:  Arch Gesamte Virusforsch       Date:  1973

4.  Separation and characterization of soluble adenovirus type 9 components.

Authors:  E Norrby; B Nyberg; P Skaaret; A Lengyel
Journal:  J Virol       Date:  1967-12       Impact factor: 5.103

5.  The soluble hemagglutinins of adenoviruses belonging to Rosen's subgroup 3. II. The slowly sedimenting hemagglutinin.

Authors:  G Wadell; E Norrby
Journal:  Arch Gesamte Virusforsch       Date:  1969

6.  Comparative studies on the soluble components of adenovirus types 9 and 15 and the intermediate strain 9-15.

Authors:  E Norby
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

7.  [Relationship between Hemagglutinin and erythrocytes in group II adenoviruses].

Authors:  P Inteewaun; R Wigand
Journal:  Z Med Mikrobiol Immunol       Date:  1967

8.  [Comparative studies on hemagglutinins of adenovurs strains of group I and II].

Authors:  W Bauer; R Wigand
Journal:  Arch Gesamte Virusforsch       Date:  1967

9.  Soluble components of adenovirus type 8.

Authors:  A Lengyel; I Nász
Journal:  J Virol       Date:  1970-10       Impact factor: 5.103

10.  Further characterization of the adenovirus erythrocyte receptor-modifying factor.

Authors:  J A KASEL; W P ROWE; J L NEMES
Journal:  J Exp Med       Date:  1961-11-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.